When was Apella founded?

Apella was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Apella located?

Apella is headquartered in San Francisco, United States.

How many employees does Apella have?

As of Dec 31, 2022, Apella has 34 employees, reflecting a 143% year-over-year growth in headcount.

Is Apella a funded company?

Apella is a funded company, having raised a total of $101M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 20, 2021.

When was the latest funding round of Apella?

Apella's latest funding was a $***** Series B round on Jan 08, 2026, with participation from 8 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $2.57B in funding in 2026 to date.

Where does Apella rank among its competitors?

Apella ranks 2nd amongst 201 active competitors, of which 68 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Apella, which secured $80M in Jan, 2026.

Who are the top competitors of Apella?

Apella's top competitors include ClearPoint Neuro, eCential Robotics and Caresyntax. Among them, Apella secured the most recent funding round in January, 2026.

Apella - 2026 Company Profile, Team, Funding & Competitors

Apella is a series B company based in San Francisco (United States), founded in 2021 by Jordan Tuttle and Cameron Marlow. It operates as a Developer of surgical systems for the operating room. Apella has raised $101M in funding from Casdin Capital and HighlandX. The company has 201 active competitors, including 68 funded and 16 that have exited. Its top competitors include companies like ClearPoint Neuro, eCential Robotics and Caresyntax.

Company Details

Developer of surgical systems for the operating room. The products of the company include sensors for operating rooms that harness artificial intelligence approaches to collect and analyze new data about surgery. It has applications targeted at improving hospital operations, surgical quality, staff training, and real-time decision-making.

Website: apella.io
Email ID: *****@apella.io

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Series B

Total Funding

$101M in 2 rounds

Latest Funding Round

Series B, Jan 08, 2026, $*****

Investors

Casdin Capital & 9 more

Ranked

2^nd among 201 active competitors

Employee Count

34 as on Dec 31, 2022

Similar Companies

ClearPoint Neuro & 156 more

View Apella's full profile

Apella is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
APELLA TECHNOLOGY INC. CIN: 84-3625528 , United States, Active	Oct 03, 2019	-	14 (As on Dec 31, 2021)	-
APELLA TECHNOLOGIES INC CIN: 843625528 , United States, Active	Dec 31, 1999	-	67 (As on Dec 31, 2024)	-

Apella has raised a total funding of $101M over 2 rounds. Its first funding round was on Dec 20, 2021. Its latest funding round was a Series B round on Jan 08, 2026 for $*****. 8 investors participated in its latest round. Apella has 10 institutional investors.

Here is the list of recent funding rounds of Apella:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 08, 2026	9965247	Series B	7184354	8561785	2473454	9236754
Dec 20, 2021	3760413	Series A	2635184	4951131	Casdin Capital	Vensana Capital & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Apella's funding rounds and investors

The founders of Apella are Jordan Tuttle and Cameron Marlow.

Here are the details of Apella's key team members:

Jordan Tuttle: Co-Founder of Apella.
Contact Info: 1 email address
Cameron Marlow: Co-Founder & CTO of Apella.
Contact Info: 1 email address

View details of Apella's Founder profiles and Board Members

Apella's employee count trend

Apella has 34 employees as of Dec 22. The total employee count is 143.0% more than what it was in Dec 21. Here is Apella's employee count trend over the years:

Uncover Apella's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Apella include ClearPoint Neuro, eCential Robotics and Caresyntax. Here is the list of Top 10 competitors of Apella, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ClearPoint Neuro 1998, Irvine (United States), Public	Developer of MRI-guided stereotactic system for neurological interventions	$33.7M	Oberland Capital, Collage Venture Partners ... & 4 others	66/100
2nd	Apella 2021, San Francisco (United States), Series B	Developer of surgical systems for the operating room	$101M	K2 HealthVentures, Casdin Capital & 8 others	66/100
3rd	eCential Robotics 2009, Gieres (France), Series C	Developer of robotic surgery platform combining imaging, navigation, and robotic assistance	$134M	Bpifrance, Caisse D Epargne & 7 others	65/100
4th	Caresyntax 2013, Boston (United States), Series C	Analytics & integration platform to improve surgical outcomes	$302M	PFM Health Sciences, IPF Partners & 25 others	65/100
5th	VitVio 2023, San Francisco (United States), Seed	AI and computer vision platform for surgical operating rooms	$10M	LDV Capital, Bek Ventures & 5 others	59/100
6th	Surgify 2015, Espoo (Finland), Series A	Develops solutions to assist healthcare providers with bone surgery	$9.69M	ZEISS, Innovestor & 8 others	59/100
7th	LensAR 2004, Orlando (United States), Acquired	Laser Technology with AR feature for cataract surgery	$99M	Aisling Capital, Florida Growth Capital & 2 others	59/100
8th	MediView 2017, Cleveland (United States), Series A	Digital medical image management tool for providers	$117M	GE HealthCare, GE Healthcare & 9 others	58/100
9th	Encare 2009, Stockholm (Sweden), Series A	Provider of web-based software platform for perioperative care to surgical clinics	$4.88M	Sting, Sciety & 2 others	57/100
10th	Caranx Medical 2020, Paris (France), Acquired	Provide of innovative surgical robotics	-	-	56/100